1. The molecular basis for peptide repertoire selection in the human leukocyte antigen (HLA) C*06:02 molecule
    Jesse I. Mobbs et al, 2017, J. Biol. Chem. CrossRef
  2. null
    Jules J. Berman, 2018 CrossRef
  3. The association of HLA-B27 and Klebsiella pneumoniae in ankylosing spondylitis: A systematic review
    Li Zhang et al, 2018, Microbial Pathogenesis CrossRef
  4. IRE1α Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases
    Raghu Patil Junjappa et al, 2018, Front. Immunol. CrossRef
  5. Distinct mechanisms survey the structural integrity of HLA-B*27:05 intracellularly and at the surface
    Zeynep Hein et al, 2018, PLoS ONE CrossRef
  6. Recent advances in ankylosing spondylitis: understanding the disease and management
    Leticia Garcia-Montoya et al, 2018, F1000Res CrossRef
  7. ERAP1-ERAP2 haplotypes are associated with ankylosing spondylitis in Polish patients
    Andrzej Wiśniewski et al, 2019, Human Immunology CrossRef
  8. Systemic rheumatic diseases: From biological agents to small molecules
    Piercarlo Sarzi-Puttini et al, 2019, Autoimmunity Reviews CrossRef
  9. Genome-wide DNA methylation analysis in ankylosing spondylitis identifies HLA-B*27 dependent and independent DNA methylation changes in whole blood
    Patrick Coit et al, 2019, Journal of Autoimmunity CrossRef
  10. HLA-B27 spondyloarthritis and spotted fever rickettsiosis: case-based review
    Albert H. Redford et al, 2019, Rheumatol Int CrossRef
  11. A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies
    Alexander Kalinkovich et al, 2019, Seminars in Arthritis and Rheumatism CrossRef
  12. null
    Jules J. Berman, 2019 CrossRef
  13. Comparison of HLA-B*27 subtypes between Chinese patients with ankylosing spondylitis and non-ankylosing spondylitis carriers
    Fangjun Luo et al, 2019, J Int Med Res CrossRef
  14. Ankylosing spondylitis: etiology, pathogenesis, and treatments.
    Wei Zhu et al, 2019, Bone Res CrossRef
  15. Indonesians Human Leukocyte Antigen (HLA) Distributions and Correlations with Global Diseases
    Krisnawan Andy Pradana et al, 2019, Immunological Investigations CrossRef
  16. HLA-B27–mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis
    Chin-Hsiu Liu et al, 2019 CrossRef
  17. Real‐time PCR based HLA‐B*27 screening directly in whole blood
    Kathrin Geiger et al, 2019, HLA CrossRef
  18. Associations of lymphotoxin-a (LTA) rs909253 A/G gene polymorphism, plasma level and risk of ankylosing spondylitis in a Chinese Han population
    Aiping Zhu et al, 2020, Sci Rep CrossRef
  19. The occurrence of sacroiliitis in HLA-B*35-positive patients with undifferentiated spondyloarthritis. A cross sectional MRI study
    Daniela Šošo et al, 2020, Clin Rheumatol CrossRef
  20. null
    Qing Cai et al, 2020 CrossRef
  21. Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials
    Philip S Helliwell et al, 2020, RMD Open CrossRef
  22. Autoimmunity, Clonal Hematopoiesis, and Myeloid Neoplasms
    Delamo I. Bekele et al, 2020, Rheumatic Disease Clinics of North America CrossRef
  23. Non-Steroidal Anti-Inflammatory Drug Etoricoxib Facilitates the Application of Individualized Exercise Programs in Patients with Ankylosing Spondylitis
    Iulia Rahela Marcu et al, 2020, Medicina CrossRef
  24. Protective effect of anthrax toxin receptor 2 polymorphism rs4333130 against the risk of ankylosing spondylitis
    Haitao Xu et al, 2020 CrossRef
  25. Screening of underlying genetic biomarkers for ankylosing spondylitis
    Xutao Fan et al, 2019, Mol Med Report CrossRef
  26. Association of IFN‐γ polymorphisms with ankylosing spondylitis risk
    Yanhui Liu et al, 2020, J Cell Mol Med CrossRef
  27. Quantitative Proteomic Analyses To Reveal the Key Features of Proteins in New Onset Ankylosing Spondylitis Patients
    Yong-Ping Lu et al, 2020, ACS Omega CrossRef
  28. Kimura's disease and ankylosing spondylitis
    Anping Chen et al, 2020 CrossRef
  29. Evaluating Inflammatory Versus Mechanical Back Pain in Individuals with Psoriatic Arthritis: A Review of the Literature
    Linda L. Grinnell-Merrick et al, 2020, Rheumatol Ther CrossRef
  30. HLA-B27-associated uveitis: an independent disease or a variant of spondyloarthritis?
    A. A. Godzenko et al, 2020, Sovremennaâ revmatologiâ CrossRef
  31. null
    Karen P. Barr et al, 2021 CrossRef
  32. HLA-B27 association of autoimmune encephalitis induced by PD-L1 inhibitor.
    Hyeyeon Chang et al, 2020, Ann Clin Transl Neurol CrossRef
  33. The association between Candida infection and ankylosing spondylitis: a population-based matched cohort study
    James Cheng-Chung Wei et al, 2020, Current Medical Research and Opinion CrossRef
  34. The Gut Microbiota and Inflammation: An Overview
    Zahraa Al Bander et al, 2020, IJERPH CrossRef
  35. Human leukocyte antigen associations with renal function among ethnic minorities in the United Kingdom
    Marcus Lowe et al, 2020, HLA CrossRef
  36. El déficit de vitamina D en pacientes con espondiloartritis en un hospital de Castilla-La Mancha
    David Castro Corredor et al, 2020, Revista Colombiana de Reumatología CrossRef
  37. Optimization of HLA-B*27 ALLELE Genotyping by PCR-SSP.
    Fernanda Formaggi Lara-Armi et al, 2020, Clinics (Sao Paulo) CrossRef
  38. miRNA-451a and miRNA-125a Expression Levels in Ankylosing Spondylitis: Impact on Disease Diagnosis, Prognosis, and Outcomes
    Dina Salem Fotoh et al, 2020, Journal of Immunology Research CrossRef
  39. Combined use of different antibody clones improves the efficiency of human leukocyte antigen B27 detection by flow cytometry
    Sándor Baráth et al, 2020, Cytometry CrossRef
  40. Associations between human leukocyte antigens and renal function
    Marcus Lowe et al, 2021, Sci Rep CrossRef
  41. Rational laboratory testing in uveitis: A Bayesian analysis
    K. Matthew McKay et al, 2021, Survey of Ophthalmology CrossRef
  42. Connection of COX-2 variants to ankylosing spondylitis susceptibility.
    Hongyun Liu et al, 2021, J Cell Physiol CrossRef
  43. Microbial-derived antigens and metabolites in spondyloarthritis
    Katharine Lu Yang et al, 2021, Semin Immunopathol CrossRef
  44. Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
    Claudia Schinocca et al, 2021, Front. Immunol. CrossRef
  45. Analysis of HLA haplotype and clinical factors during hematopoietic stem cell transplantation
    Akiko Konishi et al, 2021, Transplant Immunology CrossRef
  46. Haptoglobin and Its Related Protein, Zonulin—What Is Their Role in Spondyloarthropathy?
    Magdalena Chmielińska et al, 2021, JCM CrossRef
  47. Efficacy and safety of interleukin‐17 inhibitors in the treatment of chronic rheumatic diseases: A combined and updated meta‐analysis
    Chongru He et al, 2021, J Clin Pharm Ther CrossRef
  48. The efficacy of moxibustion and acupuncture therapy for ankylosing spondylitis
    Qingyuan Zhu et al, 2021 CrossRef
  49. HLA major allele group frequencies in a diverse population of the Free State Province, South Africa
    Walter J. Janse van Rensburg et al, 2021, Heliyon CrossRef
  50. Ultrasound-Verified Peripheral Arthritis in Patients with HLA-B*35 Positive Spondyloarthritis
    Daniela Šošo et al, 2021, Life CrossRef
  51. Lack of association between TNF polymorphism and ankylosing spondylitis susceptibility in HLA-B27-positive population: a meta-analysis
    Naiwen Hu et al, 2021, Eur Spine J CrossRef
  52. Vitamin D deficiency in patients with spondyloarthritis in a Spanish (Castilla-La Mancha) hospital
    David Castro Corredor et al, 2021, Revista Colombiana de Reumatología (English Edition) CrossRef
  53. null
    Scott M. Whitcup, 2020 CrossRef
  54. Determination of serum methylarginine levels by tandem mass spectrometric method in patients with ankylosing spondylitis
    Duygu Eryavuz Onmaz et al, 2021, Amino Acids CrossRef
  55. Significance of human leukocyte antigen-B27 expression in cases of reactive arthritis: A study in rural central India
    Jeshyca Shougrakpam et al, 2021, Saudi J Health Sci CrossRef
  56. Predominant frequency of HLA‐B*27 in patients with ankylosing spondylitis in southeastern China
    JiaoJiao Lu et al, 2021, Immun Inflamm Dis CrossRef
  57. Racial Differences in Prevalence and Treatment for Psoriatic Arthritis and Ankylosing Spondylitis by Insurance Coverage in the USA
    Alexis Ogdie et al, 2021, Rheumatol Ther CrossRef
  58. null
    Mazdak Ganjalikhani Hakemi, 2022 CrossRef
  59. null
    Shane Murray et al, 2022 CrossRef
  60. Evidence of MHC class I and II influencing viral and helminth infection via the microbiome in a non-human primate
    B. Karina Montero et al, 2021, PLoS Pathog CrossRef
  61. null
    Ira Khanna et al, 2022 CrossRef
  62. Disease modification in ankylosing spondylitis with TNF inhibitors: spotlight on early phase clinical trials
    Leticia Garcia-Montoya et al, 2021, Expert Opinion on Investigational Drugs CrossRef
  63. An Overview on the Role of Surgical Management in Ankylosing Spondylitis
    Abdullah Saeed A Alahmari et al, 2021, Arch. Pharm. Pract CrossRef
  64. Features of T lymphocyte subpopulation profile in patients with ankylosing spondylitis undergoing genetically engineered biological therapy
    A. A. Savchenko et al, 2021, Med. immunol. CrossRef
  65. Ankilozan Spondilit Ön Tanılı Hastalarda HLA-B27 Sıklığı
    Kuyaş HEKİMLER ÖZTÜRK et al, 2021 CrossRef
  66. Effectiveness of Physiotherapy in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
    Luca Pontone Gravaldi et al, 2022, Healthcare CrossRef
  67. The Prevalence of MRI-Defined Sacroiliitis and Classification of Spondyloarthritis in Patients with Acute Anterior Uveitis: A Longitudinal Single-Centre Cohort Study
    Kristyna Bubova et al, 2022, Diagnostics CrossRef
  68. Patients with ankylosing spondylitis have high risk of irritable bowel syndrome. A long-term nationwide population-based cohort study
    Hao-yuan Feng et al, 2022, Postgraduate Medicine CrossRef
  69. Tofacitinib for the treatment of active ankylosing spondylitis in adults
    Raagav Mohanakrishnan et al, 2022, Expert Review of Clinical Immunology CrossRef
  70. Reactive Arthritis After Intravesical Bacillus Calmette-Guérin Therapy
    Yoshinori Taniguchi et al, 2022, J Clin Rheumatol CrossRef
  71. Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen‐B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Philip J. Mease et al, 2022, ACR Open Rheumatology CrossRef
  72. Global Proteomic Analyses Reveals Abnormal Immune Regulation in Patients With New Onset Ankylosing Spondylitis
    Zongchao Yu et al, 2022, Front. Immunol. CrossRef
  73. Association Between Endophthalmitis and the Incidence of Acute Coronary Syndrome in Patients With Ankylosing Spondylitis: A Nationwide, Population-Based Cohort Study
    Ting-Yi Lin et al, 2022, Front. Immunol. CrossRef
  74. Dissociation of β2m from MHC class I triggers formation of noncovalent transient heavy chain dimers
    Cindy Dirscherl et al, 2022 CrossRef
  75. Population Genetics and Signatures of Selection in Early Neolithic European Farmers
    Ainash Childebayeva et al, 2022 CrossRef
  76. IL-23 in axial spondyloarthritis and psoriatic arthritis: a good fit for biological treatment?
    Fabiola Atzeni et al, 2022, Expert Opinion on Biological Therapy CrossRef
  77. Causal Relationships Between Total Physical Activity and Ankylosing Spondylitis: A Mendelian Randomization Study
    Shaojun Hu et al, 2022, Front. Immunol. CrossRef
  78. Upregulated lncRNA‐NEF predicts recurrence and poor treatment outcomes of ankylosing spondylitis
    Dapeng Han et al, 2022, Immunity Inflam & Disease CrossRef
  79. Ankylosing Spondylitis and the Risk of Lung Cancer: A Meta-Analysis and Mendelian Randomization
    Yiyuan Ao et al, 2022, Front. Genet. CrossRef
  80. Structural aspects of chemical modifications in the MHC-restricted immunopeptidome; Implications for immune recognition
    Tatyana Sandalova et al, 2022, Front. Chem. CrossRef
  81. Ezetimibe ameliorates clinical symptoms in a mouse model of ankylosing spondylitis associated with suppression of Th17 differentiation
    Jeonghyeon Moon et al, 2022, Front. Immunol. CrossRef
  82. The relationship between vitamin D receptor gene polymorphisms and ankylosing spondylitis: a systematic review, meta-analysis and trial sequential analysis
    Hang Zhou et al, 2022, Rheumatol Int CrossRef
  83. Spondyloarthritis: How far are we from precision medicine?
    Jacqueline So et al, 2022, Front. Med. CrossRef
  84. Long-Term Adherence to Etanercept in Treatment Effectiveness of Patients with Spondyloarthritis: 7-Year Data from the Iraq National Registry
    Ali Abdulrahman Younis et al, 2022, Rheumatol Ther CrossRef
  85. A Statewide Study of Cardiovascular Outcomes in Patients with Ankylosing Spondylitis
    D. Sargsyan et al, 2022, NAMJ CrossRef
  86. Features of Peripheral Blood Th-Cell Subset Composition and Serum Cytokine Level in Patients with Activity-Driven Ankylosing Spondylitis
    Pavel A. Shesternya et al, 2022, Pharmaceuticals CrossRef
  87. The value of the sacroiliac joint area as a new morphological parameter of ankylosing spondylitis
    Yun-Sic Bang et al, 2022 CrossRef
  88. Intestinal fungi and systemic autoimmune diseases
    Hua Wang et al, 2022, Autoimmunity Reviews CrossRef
  89. Enthesitis-related arthritis: the clinical characteristics and factors related to MRI remission of sacroiliitis
    Jiaoyu Li et al, 2022, BMC Musculoskelet Disord CrossRef
  90. Homotypic and heterotypic in cis associations of MHC class I molecules at the cell surface
    Fernando M. Ruggiero et al, 2022, Current Research in Immunology CrossRef
  91. Axial Spondyloarthritis: Reshape the Future—From the “2022 GISEA International Symposium”
    Fausto Salaffi et al, 2022, JCM CrossRef
  92. The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy
    Inbar Arman et al, 2022, Cells CrossRef
  93. HLA Class I Supertype Classification Based on Structural Similarity
    Yue Shen et al, 2023 CrossRef
  94. HLA-B27-positive Uveitis anterior
    Peter Werkl et al, 2023, Ophthalmologie CrossRef
  95. Vesicular traffic-mediated cell-to-cell signaling at the immune synapse in Ankylosing Spondylitis
    Fataneh Tavasolian et al, 2023, Front. Immunol. CrossRef
  96. Causal Association between Iritis or Uveitis and Glaucoma: A Two-Sample Mendelian Randomisation Study
    Je Hyun Seo et al, 2023, Genes CrossRef
  97. Emerging phagocytosis checkpoints in cancer immunotherapy
    Yu’e Liu et al, 2023, Sig Transduct Target Ther CrossRef
  98. Narcolepsy is associated with an increased risk of HLA-related autoimmune diseases: Evidence from a nationwide healthcare system data in South Korea
    Jihye Oh et al, 2023, Sleep Medicine CrossRef
  99. CURRENT TREATMENT APPROACHES IN ANKYLOSING SPONDILITIS
    Aslı Göztepe et al, 2023, tmsj CrossRef
  100. A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Tildrakizumab Efficacy and Safety in Patients With Active Ankylosing Spondylitis
    Eric Peters et al, 2023, J Clin Rheumatol CrossRef
  101. HLA B27-positive ankylosing spondylitis professional soccer player with a successful return to sports
    Eduard Bezuglov et al, 2023, The Egyptian Rheumatologist CrossRef
  102. Candidate Genetic and Molecular Drivers of Dysregulated Adaptive Immune Responses Following Traumatic Brain Injury
    Michal James Duchniewicz et al, 2023, Journal of Neurotrauma CrossRef
  103. Differentially expressed protein‐coding genes in ankylosing spondylitis: Emerging insights into pathogenesis and therapeutic approaches
    Chuyu Xiao et al, 2023, Int J of Rheum Dis CrossRef
  104. HLA-B27-positive anterior uveitis
    Peter Werkl et al, 2023, Ophthalmologie CrossRef
  105. Programmed cell death 10 can be used as a potential biomarker for ankylosing spondylitis diagnosis and treatment
    Wen-Juan Ni et al, 2023, Spinal Cord CrossRef
  106. Pro-inflammatory cytokines in spondyloarthritis: a case-control study
    Maroua SLOUMA et al, 2024, Expert Review of Clinical Immunology CrossRef
  107. Validation of diagnosis algorithms for ankylosing spondylitis in claim‐based database
    Shuo‐Yan Gau et al, 2024, Int J of Rheum Dis CrossRef
  108. Causality between Ankylosing Spondylitis and osteoarthritis in European ancestry: a bidirectional Mendelian randomization study
    Yangguang Lu et al, 2024, Front. Immunol. CrossRef
  109. Aberrant DNA Methylation Profile of Dickkopf-1 in Ankylosing Spondylitis
    Xiaoya Sun et al, 2024, Biochem Genet CrossRef
  110. The Association Between Epidermal Growth Factor rs3756261 A/G Gene Polymorphism and the Risk of Ankylosing Spondylitis in a Chinese Han Population
    Hui Zhang et al, 2024, IJGM CrossRef
  111. A novel framework for human leukocyte antigen (HLA) genotyping using probe capture-based targeted next-generation sequencing and computational analysis
    Sheng-Kai Lai et al, 2024, Computational and Structural Biotechnology Journal CrossRef